These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 31366440
1. Impact of mutations in hVISA isolates on decreased susceptibility to vancomycin, through population analyses profile - area under curve (PAP-AUC). Silveira ACO, Caierão J, Silva CI, Anzai EK, McCulloch JA, d'Azevedo PA, Sincero TCM. Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114854. PubMed ID: 31366440 [Abstract] [Full Text] [Related]
2. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K. Antimicrob Agents Chemother; 2011 Sep; 55(9):4188-95. PubMed ID: 21746940 [Abstract] [Full Text] [Related]
3. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus. Yoo JI, Kim JW, Kang GS, Kim HS, Yoo JS, Lee YS. J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215 [Abstract] [Full Text] [Related]
7. Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus. Doddangoudar VC, O'Donoghue MM, Chong EY, Tsang DN, Boost MV. J Antimicrob Chemother; 2012 Sep; 67(9):2101-6. PubMed ID: 22643192 [Abstract] [Full Text] [Related]
9. Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association. Alam MT, Petit RA, Crispell EK, Thornton TA, Conneely KN, Jiang Y, Satola SW, Read TD. Genome Biol Evol; 2014 Apr 30; 6(5):1174-85. PubMed ID: 24787619 [Abstract] [Full Text] [Related]
10. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. Bakthavatchalam YD, Babu P, Munusamy E, Dwarakanathan HT, Rupali P, Zervos M, John Victor P, Veeraraghavan B. PLoS One; 2019 Apr 30; 14(12):e0227009. PubMed ID: 31887179 [Abstract] [Full Text] [Related]
14. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain. Di Gregorio S, Fernandez S, Cuirolo A, Verlaine O, Amoroso A, Mengin-Lecreulx D, Famiglietti A, Joris B, Mollerach M. Microb Drug Resist; 2017 Jan 30; 23(1):44-50. PubMed ID: 27991847 [Abstract] [Full Text] [Related]
18. Staphylococcus aureus response and adaptation to vancomycin. Fait A, Silva SF, Abrahamsson JÅH, Ingmer H. Adv Microb Physiol; 2024 Dec 30; 85():201-258. PubMed ID: 39059821 [Abstract] [Full Text] [Related]
20. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K. Antimicrob Agents Chemother; 2014 Sep 30; 58(9):5024-35. PubMed ID: 24841271 [Abstract] [Full Text] [Related] Page: [Next] [New Search]